ROLVEDON
Total Payments
$606,411
Transactions
1,675
Doctors
1,069
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $359,578 | 773 | 571 |
| 2023 | $246,833 | 902 | 652 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $524,498 | 45 | 86.5% |
| Food and Beverage | $37,401 | 1,614 | 6.2% |
| Consulting Fee | $14,850 | 10 | 2.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,300 | 2 | 2.4% |
| Space rental or facility fees (teaching hospital only) | $12,400 | 2 | 2.0% |
| Travel and Lodging | $2,962 | 2 | 0.5% |
Payments by Type
Research
$524,498
45 transactions
General
$81,913
1,630 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SPI-GCF-104 | Spectrum Pharmaceuticals Inc. | $310,084 | 0 |
| A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients with Solid Tumors or Lymphomas and Treated with Myelosuppressive Chemotherapy | Spectrum Pharmaceuticals Inc. | $142,795 | 0 |
| Open Label Phase One Study to Evaluate Duration of Severe Neutropenia After the Same Day Dosing Time Schedules of Elfapegrastim Administration in Patients with Breast Cancer Receiving Docetaxel and Cyclophosphamide | Spectrum Pharmaceuticals Inc. | $60,840 | 0 |
| SPI-GCF-202 | Spectrum Pharmaceuticals Inc. | $10,780 | 0 |
Top Doctors Receiving Payments for ROLVEDON — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology | Reno, NV | $181.83 | 2 |
| , AGACNP | Acute Care | Houston, TX | $178.66 | 2 |
| , M.D | Specialist | Santa Monica, CA | $165.95 | 7 |
| , MD | Hematology & Oncology | Myrtle Beach, SC | $165.72 | 1 |
| , MD | Hematology & Oncology | Garland, TX | $165.51 | 7 |
| , M.D., PHD | Hematology & Oncology | Walnut Creek, CA | $163.46 | 8 |
| , FNP-BC | Family | Houston, TX | $162.42 | 1 |
| , FNP-C | Family | Houston, TX | $162.42 | 1 |
| , M.D | Medical Oncology | Fort Myers, FL | $158.27 | 1 |
| , M.D | Hematology | Fort Myers, FL | $158.26 | 1 |
| , M.D | Hematology & Oncology | Los Angeles, CA | $154.77 | 6 |
| , D.O | Hematology & Oncology | Weatherford, TX | $152.19 | 4 |
| , M.D | Hematology & Oncology | Reno, NV | $148.00 | 1 |
| , MD | Hematology & Oncology | Reno, NV | $148.00 | 1 |
| , M.D | Hematology & Oncology | Rockville, MD | $142.45 | 8 |
| , NP | Family | Waldorf, MD | $142.43 | 8 |
| , M.D | Hematology & Oncology | Woodbridge, VA | $136.29 | 7 |
| , DO | Student in an Organized Health Care Education/Training Program | Dallas, TX | $136.09 | 6 |
| , M.D | Hematology & Oncology | Wilson, NC | $134.36 | 4 |
| , M.D | Medical Oncology | Bethesda, MD | $133.13 | 3 |
| , MD | Medical Oncology | Silver Spring, MD | $131.23 | 6 |
| , M.D | Hematology & Oncology | Eglin Afb, FL | $128.94 | 6 |
| , MD | Hematology | Gainesville, FL | $125.80 | 2 |
| , M.D | Hematology & Oncology | Walnut Creek, CA | $125.69 | 6 |
| , M.D | Medical Oncology | Tinley Park, IL | $120.13 | 4 |
Ad
Manufacturing Companies
- Spectrum Pharmaceuticals Inc. $606,411
Product Information
- Type Drug
- Total Payments $606,411
- Total Doctors 1,069
- Transactions 1,675
About ROLVEDON
ROLVEDON is a drug associated with $606,411 in payments to 1,069 healthcare providers, recorded across 1,675 transactions in the CMS Open Payments database. The primary manufacturer is Spectrum Pharmaceuticals Inc..
Payment data is available from 2023 to 2024. In 2024, $359,578 was paid across 773 transactions to 571 doctors.
The most common payment nature for ROLVEDON is "Unspecified" ($524,498, 86.5% of total).
ROLVEDON is associated with 4 research studies, including "SPI-GCF-104" ($310,084).